was described. This group shows antimicrobial properties in vitro which differ fundamentally from those of benzylpenicillin and ampicillin. One member of the group, mecillinam (proposed international nonproprietary name), 6p-[(hexahydro-lH-azepin-1-yl) -methyleneamino ]-penicillanic acid (formerly called FL 1060), was selected for further study.
Mecillinam is 300 times more active in vitro against Escherichia coli than against penicillinsensitive strains of Staphylococcus aureus, whereas ampicillin is 100 times less active against the E. coli strain than against the S. aureus strain. In addition to this difference in antimicrobial spectrum there is also a difference in the mode of action, as judged from the morphological response of E. coli to the compound (1, 2, 4) and from biochemical studies (3, 5) .
In this paper the results of comparative studies of mecillinam and ampicillin will be presented.
MATERIALS AND METHODS Antibiotics. Mecillinam was used as its hydrochloride dihydrate which forms colorless crystals and is readily soluble in water. The stability of aqueous solutions depends on the pH and on the buffer system. At 37 C a 0.05% mecillinam solution in citrate buffer has a half-life of 120 h at pH 6.8 to 7.5, although it is less stable at lower pH. In phosphate buffer the half-life at pH 7.0 is only 10 h, whereas the optimum stability is at pH 5.3, with a half-life of 100 h. The substance is rapidly destroyed by sodium sulfite, bringing the half-life in Endo agar down to 45 min. Since mecillinam is a ,B-lactam antibiotic it is inactivated by various #-lactamases, although it is generally more resistant to them than ampicillin is. Mecillinam is not inactivated by amidase.
Ampicillin was used as the trihydrate and the concentrations of both compounds were calculated as the anhydrous zwitterion. Solutions of the compounds were freshly prepared.
Bacterial strains. Most of the cultures used in this study were recent clinical isolates of Enterobacteriaceae obtained from the Institute of Medical Microbiology, University of Copenhagen, or isolated from specimens submitted to our laboratory. Ten clinical isolates of Yersinia enterocolitica were obtained from Statens Seruminstitut, Copenhagen, and two reference strains (serotype 3 and serotype 9) were obtained for comparison.
Culture media. NIH agar medium or the corresponding fluid medium were used throughout the study. The medium contains 0.5% yeast extract (Difco), 1.5% casein hydrolysate (pancreatic), 0.1% dextrose, 0.25% sodium chloride, 0.005% L-cystine, and 1% agar (Oxoid no. 1) in distilled water, pH 7.1, after autoclaving.
Antibacterial activity. The antibacterial activity was determined by the conventional serial dilution technique in liquid medium. An inoculum of 104 cells per ml of medium was used. The amount of growth was read by the naked eye, after 18 h of incubation at 36 C (frequently controlled by optical density readings) and recorded as -, +, + +, + + +, or + + + +. concentration found by graphic interpolation to produce 50% inhibition of growth or + + growth as compared to the control culture (+ + + + growth).
Frequency (Fig. 3 ) was wide and varied from 0.03 ug/ml to more than 100 ug/ml. Although 50% of the isolates were inhibited by 0.3 ,sg of mecillinam per ml, 12% of the strains were not inhibited by 100 ug/ml.
Only 5% of the strains of K. pneumoniae and none of the K. oxytoca isolates were inhibited by 10 sg of ampicillin per ml, and 100 gg of ampicillin per ml did not inhibit 36% and 54% of these isolates, respectively.
The sensitivities of 26 isolates of Proteus inconstans (Providencia) (Fig. 4) to mecillinam was distributed within narrow limits and 50% of them were inhibited by 0.1 Ag/ml. In contrast, the same isolates showed a broader distribution of sensitivity to ampicillin and generally higher IC50 values, the median value being 16 ,ug/ml.
Of the Proteus vulgaris (56) and Proteus morganii (36) isolates, 21 and 47%, respectively, were not inhibited by 100 Mg of mecillinam per ml, but of the rest about 70% were inhibited by 1 ,ug/ml (Fig. 5 and 6 ). None was inhibited by 0.6 ug of ampicillin per ml and only about 40% was inhibited by 100,ug/ml.
Mecillinam was slightly more active than ampicillin against 201 Proteus mirabilis isolates (Fig. 7) , but the difference was less marked than against the other Proteus species.
In contrast to the broad distribution of the sensitivities to mecillinam of isolates belonging to Proteus and Klebsiella species, 12 clinical strains of Y. enterocolitica were all inhibited by 0.03 to 0.05 Mg of mecillinam per ml and by 16 ug of ampicillin per ml.
A comparison of the sensitivities of the 236 Escherichia coli isolates to mecillinam and ampicillin is shown in Fig. 8 . The geometric mean of the IC50 values of mecillinam (0.07 Mg/ml) was 40 times less than those of ampicillin (2.8,ug/ml). The straight line represents the expected regression line if all isolates were 40 times more sensitive to mecillinam than to ampicillin, i.e., if the difference between the two compounds was only quantitative and not qualitative. However, as the distribution of the sensitivity to ampicillin ranged from 0.2 Mg/ml to more than 100 ,ug/ml for isolates that showed sensitivities to mecillinam about the mean IC,0 value of 0.07 Mg/ml, there was no evidence of cross-resistance between the two antibiotics. This is consistent with the difference in the mode of action of the two compounds (3, 4, 5 ). An apparent cross-resistance exists for strong ,B-lactamase producers as both antibiotics are inactivated by these enzymes. Preliminary experiments in our laboratory have suggested a difference in sensitivity to various ,-lactamases. Generally mecillinam is more stable than ampicillin in cultures of ,B-lactamase producers (6) .
Protein binding. The binding of mecillinam to human serum determined by the ultrafiltration technique was found to be about 5 to 10%, i.e., only one-quarter to one-half that of ampicillin.
Influence of pH. The activity of mecillinam against three species of bacteria tested in liquid media at varying initial pH's is shown in 1. It will be seen that the activity was relatively independent of pH between 5.5 and 8.0. Frequency and selection of insensitive variants. A population analysis of a strain of S. typhimurium and of E. coli was made by counting the number of colony-forming units on agar media containing various concentrations of mecillinam or ampicillin. After 72 h of incubation the two strains showed a heterogeneous distribution of sensitivity to mecillinam (Fig. 9  and 10 ). This heterogeneity was due to the occurrence of slow-growing, morphologically altered cells. Successive transfers of bacteria from plates containing 1, 10, and 100 sg of mecillinam per ml were made into liquid media containing no meciUinam. After an overnight incubation the cells had returned to normal shape. A repeated analysis, made after the first transfer in drug-free media, showed that the viable counts were only affected by concentrations of more than 30 jg/ml (Fig. 11) . The isolates from the 1-and 10-jg/ml plates (Fig. 10) . The frequency increased by a factor of 6 when the medium contained 0.8% sodium chloride and decreased by a factor of 15 when sodium chloride was omitted. developed few normal-growing colonies on the control plates in 18 h. After the second transfer the number of resistant cells decreased 100-to 1,000-fold and after the fifth transfer the distributions were similar to that of the original strain. However, the strains isolated from 1- and 10-,ug/ml plates contained fewer resistant bacteria than the original strain, but gradually became indistinguishable from the latter after further transfers.
It was thus possible to select resistant variants from the original strain. The sensitivity of
